Latest Stock Split Details
Key information about Oncternal Therapeutics, Inc.'s most recent stock split
Split Date: 2024-01-08
Split Ratio: 1:20
Price Before Split: $0.36
Price After Split: $0.02
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Oncternal Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-01-08 | 1:20 | Yes | $0.36 | $0.02 |
| 2019-06-10 | 1:7 | Yes | $1.02 | $0.15 |
| 2016-12-06 | 1:10 | Yes | $0.07 | $0.01 |
About Oncternal Therapeutics, Inc.
Company overview and industry information
Oncternal Therapeutics, Inc. (ONCT) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Oncternal Therapeutics, Inc. Summary